LG Chem, Ltd

Products

EUTROPIN Somatropin

    • Product Name: EUTROPIN Somatropin
    • Chemical Name (IUPAC): Somatropin
    • CAS No.: 12629-01-5
    • Chemical Formula: C990H1528N262O300S7
    • Form/Physical State: Lyophilized Powder
    • Factroy Site:
    • Price Inquiry: sales6@ascent-chem.com
    • Manufacturer: LG Chem, Ltd
    • CONTACT NOW
    VTB
    Specifications
    HS Code 659512
    Brand Name Eutropin
    Generic Name Somatropin
    Drug Class Growth Hormone
    Manufacturer LG Chem
    Route Of Administration Subcutaneous injection
    Indication Growth hormone deficiency
    Dosage Form Injection
    Strength 4 IU/vial
    Prescription Status Prescription only
    Storage Temperature 2°C to 8°C
    Active Ingredient Somatropin
    Country Of Origin South Korea
    Atc Code H01AC01
    Primary Use Increase linear growth in children and adults
    Packaging Vial with diluent

    As an accredited EUTROPIN Somatropin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing EUTROPIN Somatropin packaging features a white box with blue accents, containing 10 vials, each with 4 IU (1.33 mg).
    Container Loading (20′ FCL) Container Loading (20′ FCL): EUTROPIN Somatropin securely packed in temperature-controlled conditions; ensures product stability and compliance during shipment.
    Shipping EUTROPIN Somatropin is shipped in temperature-controlled packaging to preserve its stability and efficacy. The product is delivered with cold packs and insulation, ensuring it remains within the recommended storage range throughout transit. Shipments are expedited, typically requiring a signature upon delivery to maintain product integrity and ensure safe handling.
    Storage EUTROPIN Somatropin should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep the vial or cartridge in the original packaging until use. Once reconstituted, use within the period specified in the instructions, and do not shake the solution. Keep out of reach of children.
    Shelf Life EUTROPIN Somatropin has a shelf life of 24 months when stored at 2–8°C, protected from light and freezing.
    Application of EUTROPIN Somatropin

    Applications of EUTROPIN Somatropin in Industrial Manufacturing

    EUTROPIN Somatropin serves essential functions in multiple regulated industries. Its utilization demands careful process integration, strict compliance, and tailored formulation to meet diverse end-product requirements. Below, we outline key downstream industrial applications with detailed segmentation, standards, dosing, integration points, and typical finished products.

    1. Recombinant Biopharmaceutical Production

    Biopharmaceutical manufacturers utilize recombinant somatropin as the active pharmaceutical ingredient (API) for injectable drug products. GMP bioreactor facilities employ standardized fermentation followed by multi-stage purification. Accurate dosing throughout upstream and downstream processing is mandated by strict pharmacopoeial specifications. Quality assurance for both intermediate and final product confirms compliance with relevant pharmacopeias and regulatory submissions. Product is released as finished sterile APIs or pre-filled syringes and vials for clinical and commercial use.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Biosimilar Development and Clinical Trials

    Companies involved in biosimilar development use somatropin as reference standard and API for pilot and clinical material. Regulatory submissions require demonstration of consistent expression, purity, and activity compared to branded biologics. Dose-ranging studies and batch comparisons depend on consistent process control and analytical validation. The final output supports clinical supply for Phase I–III studies, batch comparability, and regulatory filings in multiple jurisdictions.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Veterinary Biologic Formulation

    Animal health firms apply somatropin as an active protein for veterinary growth promotion and metabolic modulation. The formulation requires adherence to animal-use monographs and veterinary GMP protocols. Exact concentration in finished veterinary medicines balances animal species requirements, approved dose schedules, and pharmacodynamic data. Integration steps include aseptic formulation, fill-finish, and labeling as per authorized veterinary licenses.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Diagnostic Standards and QC Reference Material

    In vitro diagnostics and research laboratories use somatropin as a calibrator or reference in immunoassay kits and chromatographic analysis. Production demands high purity and documented bioactivity. The material serves as quantitative standard for analytical performance checks, calibration curves, and proficiency testing. Formulation and fill are tailored for kit integration and secondary reference provisioning.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. Cell Culture Supplement in Bioprocessing

    Bioprocessing firms employ somatropin as a media supplement in cell culture systems requiring growth stimulation or for development of recombinant producer lines. Proper addition enhances productivity of mammalian cells in hybridoma or recombinant protein production. Usage protocols depend on cell type, process stage, and critical quality parameters. All supplementation follows GMP-grade sourcing and batch documentation, particularly for downstream pharmaceutical use.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive EUTROPIN Somatropin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618018036652

    Email: sales6@ascent-chem.com

    Inquiry

    Get Free Quote of LG Chem, Ltd

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing EUTROPIN Somatropin: Genuine Manufacturer Insights

    The Drive Behind EUTROPIN Somatropin

    In the world of human growth hormone, precision takes on new meaning with EUTROPIN Somatropin. As the actual manufacturer, not a mere reseller or third-party distributor, we have lived every challenge involved—from fermentation tank to finished vial. Every lot reflects our experience with strain development, raw material scrutiny, and years of observing the needs of endocrinologists, pharmacists, and especially patients who place their trust in us. We oversee the entire journey, which brings valuable perspective on what truly matters.

    Demand for recombinant human growth hormone has grown alongside clinical recognition of adult and pediatric growth disorders. Doctors need reliable options, and families deserve safe, reproducible therapies—not only for classic growth hormone deficiency but also for Turner syndrome, chronic kidney disease, and even certain cachectic conditions. Our team hears from clinicians about the balance between potency and predictability. Consistent protein yield and verified bioactivity stand out as points of reassurance. We have honed our process, integrating feedback, clinical expectations, and real-life experience from end-to-end handling.

    Model and Specification Built for Real-Life Use

    EUTROPIN Somatropin comes in vials tailored for injection. Each vial contains the recombinant somatropin protein, standardized at 4 IU or 10 IU per vial, based on our process scale and validation data. The white lyophilized powder easily dissolves with supplied sterile water for injection, minimizing air bubble formation and allowing for gentle reconstitution—a real need we learned about from hospital pharmacy teams, whose job it is to prepare doses quickly and safely.

    Every lot is tracked from molecular cloning through fermentation in E. coli, induction, purification, and lyophilization. Purity standards stand at >96% by RP-HPLC and SDS-PAGE, a figure we do not claim lightly. This benchmark comes not just from regulatory files but from our grime-under-the-nails daily batch analytics, looking for any sign of truncated species or aggregate. Endotoxin levels remain tightly controlled, well below the accepted pharmacopoeia limits. Each batch clears rigorous pyrogenicity and sterility testing, because we recognize the risks for pediatric and immunocompromised users. Impurities, including host cell proteins, are calculated down to fractions of a microgram, using in-house ELISA technologies tuned over years for reliability.

    We offer both single-use and multi-use presentations, with clear expiration markings and lot numbers directly printed—not stickered—onto primary packaging. This seemingly simple detail came out of real-world feedback from nurses and hospital pharmacists weary of label mix-ups and worried about storage error. It’s a practical change that many overlook, but it came directly from our own audit trails and post-market surveillance reports.

    Practical Dosage and Handling Insights

    Route of administration remains subcutaneous or intramuscular, with most practitioners preferring subcutaneous due to ease and patient comfort. Reconstitution happens right before use. We’ve kept excipients simple, relying on mannitol and a carefully balanced phosphate buffer, because real-world reports taught us that complex mixtures sometimes led to clumping or inconsistent absorption. For multi-dose use, we issue clear instructions on in-fridge storage and maximum duration after reconstitution—no vagueness, no unnecessary shelf-life padding, just results informed by our own stability testing and real practitioner experience.

    Dosing schedules are guided by prescriber assessment, adjusted by clinical need—whether daily, several times weekly, or as per individual profiles. In our direct communication with physician panels, we've heard a consistent concern about variable absorption rates, so we conduct ongoing in vivo bioavailability tests to measure and calibrate serum IGF-1 response among volunteers and research partners. This allows us to provide clear, evidence-based information to those making the prescribing decisions.

    Our packaging also reflects enduring hospital feedback—robust ampoules for solvent and glass designed for breakage resistance. Patients seeing the product at home find clear, simple instructions and no-nonsense labeling, limiting confusion between lot numbers, expiry, and storage steps. A hospital technician pointed out during a visit: "The fewer unpacking steps, the less chance for error." We took that lesson seriously, changing our kit layout so each part stands on its own, not buried in complicated inserts.

    Distinguishing EUTROPIN Somatropin from Other Options

    Over two decades spent developing recombinant proteins have exposed us to every debate on “bioequivalence” and “biosimilarity.” The question arises—what makes EUTROPIN Somatropin stand out, aside from the established sequence identity with human growth hormone? The difference emerges from gritty, granular work. We handle the upstream (gene expression and fermentation), downstream (purification and folding), and regulatory steps ourselves. This means quality doesn’t hinge on subcontractors or shifting priorities from a parent conglomerate.

    Many hormones on the market today trace their bioactivity to fermentation in yeast, or generic E. coli expression without proprietary folding and recovery sequences. During scale-up, subtle changes in oxygenation or feeder media can trigger tiny differences in glycation or microaggregates, unnoticed until a patient reports redness or pain at injection. Our site controls every batch parameter, so traceability never disappears into a black box. If a rare side effect or manufacturing inconsistency appears, we track it through in-house analytics, not third-party paperwork.

    Alternative brands sometimes market themselves with elaborate delivery devices or complex additive blends, but we have focused on stability and genuine value for hospitals and patients. While patients receiving biosimilar hormones deserve assurance, the best marker for confidence comes from a straightforward, unbroken manufacturing chain. We stand behind every order with a full record, ready to answer tough regulatory and clinical questions with our own track data.

    Another frequent talking point is immunogenicity. We publish our aggregate anti-GH antibody rates per lot, available to partner physicians and regulatory bodies alike. This transparency reflects a manufacturing philosophy: real trust grows from shared clinical outcomes, not PowerPoint presentations.

    Accessible Manufacturing and Full Traceability

    It’s tempting to gloss over the complexity of large-scale protein manufacturing, but every technician and quality manager knows the headaches of keeping contaminants out, batches reproducible, and costs under control. We maintain complete vertical integration—which means the gene sequence, E. coli seed lots, purification protocols, and lyophilization cycles originate, develop, and reach completion exclusively at our facility.

    No mystery customs brokers or third-country re-porting. We pass audits because our work matches our documentation. From the pipette tip to pallet load, we welcome regulatory review and routinely host teams representing diverse compliance systems. Every year, inspectors run through our original SOPs, batch logs, and deviation reports. We demonstrate traceability and root cause analysis with the actual people who made the product—not hired consultants reading printouts. This approach requires real investment in training, cross-team feedback, and a company culture willing to listen not just to regulators but to every user and partner along the chain.

    Once, a batch deviation was caught by an alert process technician—not by a software alarm, but by experience earned over a decade monitoring tank aeration. That batch never left the plant. Learning from ground-level feedback keeps problems small, rather than inviting large-scale recalls after the fact. That’s a manufacturers’ perspective—and one that traders or distributors will never understand.

    Patient and Practitioner Experiences Shape Refinement

    A major medical center reached out to us recently with an inquiry about inconsistent reconstitution times across different hormone brands. We set up direct visits and in-practice demonstrations, not marketing webinars. After seeing their workflow, we modified particulate analysis and adopted a more robust filling needle size, eliminating a lag nurse teams had flagged. Every tweak comes from real practice—not just laboratory statistics.

    On the patient side, anecdotal feedback carries enormous weight. Families have voiced gratitude for straightforward preparation and reliable refill schedules. Some adults undergoing hormone replacement tell us about injection site comfort, the difference between smooth dissolution and inconsistent powders, and even package size’s impact on their travel and everyday management. Unlike the mass-produced, supermarket approach to biologics, we consider these stories essential. They are not marketing testimonials—just the reality check that much of the world’s manufacturing process forgets.

    Support doesn’t end with a batch shipped to a pharmacy shelf. We regularly work with specialty clinics to review outcomes, both positive trends and rare adverse events. This helps practitioners fine-tune regimens for Turner syndrome, short stature, or growth impairment arising from long-standing renal conditions. Together with physician partners, we continuously refine clear guidelines for administration, rotation of injection sites, and monitoring of serum IGF-1. This cycle of feedback and practical data creates lasting improvements which can’t be faked—a lesson learned from decades in direct manufacturer-to-clinician engagement.

    Understanding Regulatory and Safety Priorities

    Our years of manufacturing protein drugs have taught us that compliance does not begin and end with batch release. Regulatory reporting, lot-to-lot consistency, and adverse event follow-up remain equally important. We employ a transparent reporting system—direct from quality control to national and regional pharmacovigilance bodies. Every recall notice (they can happen, although thankfully rarely) and every notification runs through internal traceability audits. Having to face ministers of health, insurance committees, and hospital procurement boards means standing behind quality in every conversation. This culture comes only when the manufacturing staff drives both production standards and clinical support.

    We continue to invest in more sensitive detection methods, from liquid chromatography to next-generation sequencing for host-cell DNA remnants. This isn’t regulatory box-checking—it comes directly from our experience dealing with evolving expectations among healthcare partners. More than once, new insights from these investments have led to refinements beyond what guidance documents demanded, improving our product’s safety and reliability before a single report made it back to regulatory authorities. Manufacturing from the source means acting before problems scale, keeping improvement ongoing instead of reactive.

    Future Directions Shaped by Grounded Experience

    Every advancing year brings new challenges and expectations for hormone manufacturers. Emerging research on somatropin’s impact on metabolic syndromes, chronic pediatric illness, and aging populations keeps us close to the specialists at the front line. As gene therapies and more personalized routines reshape the standard of care, our manufacturing strategy adapts. We’ve started integrating ongoing training about genomics, big-data clinical monitoring, and advanced protein analytics. Our site-based teams build on practical knowledge as much as scientific advancement.

    The next generation of EUTROPIN products will draw heavily from this blend—retaining the reliability, batch control, and practitioner trust that come only from day-to-day, decade-long manufacturer involvement. Future improvements in device design, dosing flexibility, and even digital support for patients will rest squarely on the shoulders of production teams, quality analysts, and medical liaisons who see the impact, not just the paperwork.

    Why Manufacturing Perspective Matters

    Many in the broader market don’t appreciate the consequences of a true risk—from minor labeling error to a misunderstood batch deviation. As the manufacturer, we’ve lived the cost of every improvement and the relief of every clean batch cleared by both regulators and real-world use. Those who pick products based on price or branding miss the value embedded in trust that only the originator of the molecule can guarantee.

    That trust isn’t effortless or automatic. It comes from putting boots on the floor, talking to doctors and nurses, and listening to families, not just spreadsheet data. Mistakes become lessons when the manufacturer holds responsibility for every molecule, label, and outcome.

    In Summary: EUTROPIN Somatropin by the People Who Make It

    EUTROPIN Somatropin stands as more than just a recombinant growth hormone. Every detail represents hundreds of hours addressing frontline feedback, observing dose preparation, studying adverse events, and sharpening process controls. Model and specifications reflect not just what regulations demand but what long-term practitioner and patient interactions prove necessary for safe, effective therapy. Differences from competing options lay not only in analytical values but in the certainty that comes from no detours, no guesswork, and no handoffs to third parties.

    Integration, hands-on experience, and responsive manufacturing are the distinguishing features that define EUTROPIN Somatropin. These don’t show up on a marketing spreadsheet, but they do shape every dose and every patient’s outcome. Across all these years, genuine improvement and trust stem from one place: the experience of making the product and bringing it directly to the people who depend on it.